GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Scaled Net Operating Assets

Kangstem Biotech Co (XKRX:217730) Scaled Net Operating Assets : 0.52 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kangstem Biotech Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Kangstem Biotech Co's operating assets for the quarter that ended in Dec. 2024 was ₩37,719 Mil. Kangstem Biotech Co's operating liabilities for the quarter that ended in Dec. 2024 was ₩4,348 Mil. Kangstem Biotech Co's Total Assets for the quarter that ended in Sep. 2024 was ₩64,128 Mil. Therefore, Kangstem Biotech Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.52.


Kangstem Biotech Co Scaled Net Operating Assets Historical Data

The historical data trend for Kangstem Biotech Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangstem Biotech Co Scaled Net Operating Assets Chart

Kangstem Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 0.28 0.23 0.26 0.41

Kangstem Biotech Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.28 0.38 0.42 0.52

Competitive Comparison of Kangstem Biotech Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Kangstem Biotech Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kangstem Biotech Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kangstem Biotech Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Kangstem Biotech Co's Scaled Net Operating Assets falls into.


;
;

Kangstem Biotech Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Kangstem Biotech Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(37719.38-4348.115)/81253.041
=0.41

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=55986.114 - 18266.734
=37719.38

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=12804.093 - 4408.289 - 4047.689
=4348.115

Kangstem Biotech Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(37719.38-4348.115)/64127.971
=0.52

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=55986.114 - 18266.734
=37719.38

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=12804.093 - 4408.289 - 4047.689
=4348.115

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kangstem Biotech Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Kangstem Biotech Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangstem Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
512 Teheran-ro, Gangnam-gu, 17th Floor, Sinan Building, Seoul, KOR
Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.

Kangstem Biotech Co Headlines

No Headlines